Possible role of macrophage-like suppressor cells in the anti-tumour activity of BCG
Open Access
- 1 December 1981
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 44 (6) , 828-837
- https://doi.org/10.1038/bjc.1981.281
Abstract
The i.v. injection of high doses (3 mg) of BCG into C3H mice bearing a transplantable 3-methylcholanthrene-induced fibrosarcoma caused the regression of a significant proportion. This effect was most evident when the BCG was injected on the day of the graft, or 7 days later. The injection of this agent either 14 days before the graft, or in low doses (0.1 or 0.5 mg), or directly into the tumour (i.t.) only prolonged the survival of the animals. Spleen cells from systemic high-dose BCG-treated mice were found to exert a strong nonspecific cytostatic effect in vitro that was not an artefact of the test conditions, and was not expressed by cells from low-dose animals. The cytostatic effect was shown to be caused by cells with the characteristics of macrophages, i.e. they were strongly adherent, unaffected by treatment with anti-Thy 1.2 + C', radioresistant but heat-sensitive, and were detected in BCG-treated "B" mice. The spleens of high-dose BCG-treated mice also contained suppressor cells that were capable of inhibiting the in vitro reactivity of normal T cells to PHA. Like the cytostatic effect, this suppressor activity was not detected in low-dose mice, and the cells responsible had the properties of macrophages, the effect was lost after the removal of adherent cells by sequential exposure to plastic and colloidal iron, but was conserved after treatment with anti-Thy 1.2 + C'. T-cell-deprived animals, such as "B" or nude mice, also developed suppressor-cell activity when treated with systemic high-dose BCG. Close parallels became evident between the in vivo anti-tumour activity of BCG, the in vitro cytostatic effect, and the suppressor-cell activity. We here discuss the possible role of suppressor cells in the mechanism of action of this agent.Keywords
This publication has 34 references indexed in Scilit:
- The antileukemic effect of systemic non-specific BCG-immunostimulation vs systemic specific immunostimulation with irradiated isogeneic leukemic cellsPublished by Elsevier ,1978
- T-dependent suppression of the primary antibody response to sheep erythrocytes in mice infected with Trichinella spiralisCellular Immunology, 1976
- Hodgkin's disease. An immunodepleting and immunosuppressive disorder.Journal of Clinical Investigation, 1975
- Immune manipulation by BCG administered before or after cyclophosphamide for chemo-immunotherapy of L1210 leukaemiaPublished by Elsevier ,1974
- Depression of delayed-type hypersensitivity by Corynebacterium parvum: Mandatory role of the spleenCellular Immunology, 1974
- THE THYMIC SUPPRESSOR CELLThe Journal of Experimental Medicine, 1974
- A rapid method for the isolation of functional thymus‐derived murine lymphocytesEuropean Journal of Immunology, 1973
- Culture conditions affecting induction and release of lymphocyte produced proliferation inhibitory factor (PIF)Cellular Immunology, 1973
- IMMUNOPROPHYLAXIS AND IMMUNOTHERAPY OF LEUKÆMIA WITH B.C.G.The Lancet, 1972
- Mechanism of Immunologically Specific Killing of Tumour Cells by MacrophagesNature, 1972